MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome.
about
MCAF mediates MBD1-dependent transcriptional repressionNormal histone modifications on the inactive X chromosome in ICF and Rett syndrome cells: implications for methyl-CpG binding proteinsGene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutationsEpigenetics and assisted reproductive technology: a call for investigation.Rett syndrome with colon cancer presented with sigmoid volvulus: Report of a case.Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.Setdb1-mediated histone H3K9 hypermethylation in neurons worsens the neurological phenotype of Mecp2-deficient mice.MeCP2 and other methyl-CpG binding proteins.Dynamic changes in Histone H3 lysine 9 acetylation localization patterns during neuronal maturation require MeCP2.Gametes and embryo epigenetic reprogramming affect developmental outcome: implication for assisted reproductive technologies.Enhancer of polycomb coordinates multiple signaling pathways to promote both cyst and germline stem cell differentiation in the Drosophila adult testis.Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures.Gene clusters, molecular evolution and disease: a speculation.Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognitionA moment's pause: putative nucleosome-based influences on MeCP2 regulation.Lysine Acetylation and Deacetylation in Brain Development and NeuropathiesThe chromatin-remodeling BAF complex mediates cellular antiviral activities by promoter priming.Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.Methylation-dependent silencing at the H19 imprinting control region by MeCP2In vivo repression of an erythroid-specific gene by distinct corepressor complexes.High-resolution genome-wide mapping of histone modifications.MeCP2 expression in human cerebral cortex and lymphoid cells: immunochemical characterization of a novel higher-molecular-weight form.Rett Syndrome.Review article: Breaking new ground with Rett syndrome
P2860
Q24298813-E93B6847-B796-4461-855C-F3F1303E0EEAQ24798816-B78B8D1A-8F88-4300-ABD1-CE7461855870Q24799191-51C5E7B9-15F4-44DE-8124-097AAFC8CC94Q33909693-590F5C57-A83D-47A4-864F-8C56CF5F23BDQ34359158-EB748901-63BD-4BB0-93C4-68C6561E0B0BQ34372135-D7E15761-8208-4393-9E17-D43901049988Q34511024-372D356D-3EEB-4371-ABBB-B4070CA25D92Q34733505-76D2BC1A-BAFC-4665-8564-91E811ABC773Q35762162-58A1CF5A-B7A1-476F-A139-D98C9273C2DCQ36251483-E7583EE2-61F1-43D1-8120-09CB09955FAAQ36279837-CA60B586-B90E-4EAE-894F-83F60D26850AQ37173776-26418A05-C1A8-42EF-A86A-D29379E63561Q37236200-53FD8031-ADD7-41BD-8D9B-44C9AEBCACA5Q37279844-941E8A68-42F3-4650-BB7F-29FE55F58FE5Q37629624-2EAEF18C-1833-4237-9B4E-A1C0D29C2E2DQ37683341-B9FBC3CD-E5CC-4A20-B275-9CB86E6FB54AQ37732177-085BDBFB-7544-4568-8A35-BFC333776E71Q39528996-1E0A3058-8FE0-4637-B783-B13CD5BAE41FQ39535251-F376FC2A-B053-459A-95B6-DA04B1EE13C1Q39644809-1B6F8049-BC74-4FAF-B943-A34030469F99Q47244312-A5F18FAC-F461-4507-B14B-9B56F0B1EFB0Q47358419-62D6F003-9206-473D-8ECA-3D994A58AACCQ55056221-FF85A766-0D36-453C-BCD5-1B187BA1E1AFQ56551921-0B7A50EF-817C-4E6D-AC15-E741B42C3589
P2860
MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome.
@en
type
label
MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome.
@en
prefLabel
MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome.
@en
P2093
P356
P1476
MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome.
@en
P2093
P304
P356
10.1093/HMG/10.10.1085
P577
2001-05-01T00:00:00Z